SCHEMBL4141870

SCHEMBL4141870

CC1(C)O[C@H]2[C@@H]([C@H](O)CO)OC(=O)[C@H]2O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ MANBA O00462 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ CYP1A2 P05177 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ CYP2C19 P33261 1/20 0.33
▸ GLB1 P16278 1/20 0.32
▸ MGAM O43451 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13106543 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL19146568 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL4131205 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL19146746 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL2159235 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL23288111 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL19129777 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL19129720 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL12396147 1.00 LMNA (0.47) LMNAHIF1AMANBATHRBCYP1A2
SCHEMBL13772994 0.89 MANBA (0.36) LMNAHIF1AMANBATHRBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090182154-A1 Combinatorial library approach to iminocyclitols with biological activity UNITED THERAPEUTICS CORPORATION 2009-07-16 — — US disclosed
US-20070088164-A1 Combinatorial library approach to iminocyclitols with biological activity MORIARITY ROBERT M 2007-04-19 — — US disclosed
US-5153325-A Catalytic hydrogenation of protected azido-L-gulo-heptulose with platinum/iv/ oxide, deprotection of iminoheptitol by hydrolysis MONSANTO COMPANY (US) 1992-10-06 — — US disclosed
US-5096909-A Imino-trideoxy-glycero-gluco heptitol MONSANTO COMPANY (US) 1992-03-17 — — US disclosed
US-5017704-A 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco heptitol MONSANTO COMPANY (US) 1991-05-21 — — US disclosed
EP-0409812-A2 Fucosidase inhibitor MONSANTO COMPANY (US) 1991-01-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088164-A1 Combinatorial library approach to iminocyclitols with biological activity PAICS, IMPDH1, UGCG LMNA 843/4885HIF1A 519/4885MANBA 25/4885
US-20090182154-A1 Combinatorial library approach to iminocyclitols with biological activity PAICS, IMPDH1, UGCG LMNA 843/4885HIF1A 519/4885MANBA 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback